These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 35549858)
1. Antidiabetic Agents from Fungi with Special Reference to α-Glucosidase Inhibitors. Deshmukh SK; Gupta MK; Agrawal S Recent Pat Biotechnol; 2023; 17(1):24-61. PubMed ID: 35549858 [TBL] [Abstract][Full Text] [Related]
2. Coumarin-based Scaffold as α-glucosidase Inhibitory Activity: Implication for the Development of Potent Antidiabetic Agents. Tafesse TB; Bule MH; Khoobi M; Faramarzi MA; Abdollahi M; Amini M Mini Rev Med Chem; 2020; 20(2):134-151. PubMed ID: 31553294 [TBL] [Abstract][Full Text] [Related]
3. α-Glucosidase inhibitory effect of resveratrol and piceatannol. Zhang AJ; Rimando AM; Mizuno CS; Mathews ST J Nutr Biochem; 2017 Sep; 47():86-93. PubMed ID: 28570943 [TBL] [Abstract][Full Text] [Related]
4. Utilization of Fishery Processing By-Product Squid Pens for α-Glucosidase Inhibitors Production by Paenibacillus sp. Nguyen VB; Nguyen AD; Wang SL Mar Drugs; 2017 Aug; 15(9):. PubMed ID: 28867763 [TBL] [Abstract][Full Text] [Related]
5. A systematic review of the inhibitory effect of extracts from edible parts of nuts on α-glucosidase activity. Farazi M; Houghton MJ; Murray M; Williamson G Food Funct; 2023 Jul; 14(13):5962-5976. PubMed ID: 37306209 [TBL] [Abstract][Full Text] [Related]
6. Critical Assessment of In Vitro Screening of α-Glucosidase Inhibitors from Plants with Acarbose as a Reference Standard. Miller N; Joubert E Planta Med; 2022 Oct; 88(12):1078-1091. PubMed ID: 34662924 [TBL] [Abstract][Full Text] [Related]
7. Naturally occurring sulfonium-ion glucosidase inhibitors and their derivatives: a promising class of potential antidiabetic agents. Mohan S; Eskandari R; Pinto BM Acc Chem Res; 2014 Jan; 47(1):211-25. PubMed ID: 23964564 [TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of novel xanthone-triazole derivatives as potential antidiabetic agents: α-Glucosidase inhibition and glucose uptake promotion. Ye GJ; Lan T; Huang ZX; Cheng XN; Cai CY; Ding SM; Xie ML; Wang B Eur J Med Chem; 2019 Sep; 177():362-373. PubMed ID: 31158750 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of black tea and its combination with acarbose on small intestinal α-glucosidase activity. Satoh T; Igarashi M; Yamada S; Takahashi N; Watanabe K J Ethnopharmacol; 2015 Feb; 161():147-55. PubMed ID: 25523370 [TBL] [Abstract][Full Text] [Related]
10. Lactobacillus strains isolated from infant faeces possess potent inhibitory activity against intestinal alpha- and beta-glucosidases suggesting anti-diabetic potential. Panwar H; Calderwood D; Grant IR; Grover S; Green BD Eur J Nutr; 2014 Oct; 53(7):1465-74. PubMed ID: 24414142 [TBL] [Abstract][Full Text] [Related]
11. Natural Triterpenoids Isolated from Akebia trifoliata Stem Explants Exert a Hypoglycemic Effect via α-Glucosidase Inhibition and Glucose Uptake Stimulation in Insulin-Resistant HepG2 Cells. Bian G; Yang J; Elango J; Wu W; Bao B; Bao C Chem Biodivers; 2021 May; 18(5):e2001030. PubMed ID: 33779055 [TBL] [Abstract][Full Text] [Related]
12. Flavonoids as potential agents in the management of type 2 diabetes through the modulation of α-amylase and α-glucosidase activity: a review. Proença C; Ribeiro D; Freitas M; Fernandes E Crit Rev Food Sci Nutr; 2022; 62(12):3137-3207. PubMed ID: 33427491 [TBL] [Abstract][Full Text] [Related]
13. In Vitro Evaluation of α-amylase and α-glucosidase Inhibition of 2,3-Epoxyprocyanidin C1 and Other Constituents from Feunaing RT; Tamfu AN; Gbaweng AJY; Mekontso Magnibou L; Ntchapda F; Henoumont C; Laurent S; Talla E; Dinica RM Molecules; 2022 Dec; 28(1):. PubMed ID: 36615320 [TBL] [Abstract][Full Text] [Related]
14. Tyramine Derivatives as Potent Therapeutics for Type 2 Diabetes: Synthesis and Bashir MA; Javaid K; Shaikh M; Choudhary MI; Siddiqui H Med Chem; 2020; 16(8):1124-1135. PubMed ID: 32003674 [TBL] [Abstract][Full Text] [Related]
15. Synthesis & α-glucosidase inhibitory & glucose consumption-promoting activities of flavonoid-coumarin hybrids. Sun H; Song X; Tao Y; Li M; Yang K; Zheng H; Jin Z; Dodd RH; Pan G; Lu K; Yu P Future Med Chem; 2018 May; 10(9):1055-1066. PubMed ID: 29676183 [TBL] [Abstract][Full Text] [Related]
16. Towards multi-target antidiabetic agents: In vitro and in vivo evaluation of 3,5-disubstituted indolin-2-one derivatives as novel α-glucosidase inhibitors. Klochkov VG; Bezsonova EN; Dubar M; Melekhina DD; Temnov VV; Zaryanova EV; Lozinskaya NA; Babkov DA; Spasov AA Bioorg Med Chem Lett; 2022 Jan; 55():128449. PubMed ID: 34780899 [TBL] [Abstract][Full Text] [Related]
17. Synthetic α-glucosidase inhibitors as promising anti-diabetic agents: Recent developments and future challenges. Mushtaq A; Azam U; Mehreen S; Naseer MM Eur J Med Chem; 2023 Mar; 249():115119. PubMed ID: 36680985 [TBL] [Abstract][Full Text] [Related]
18. An Updated Overview of Synthetic α-glucosidase Inhibitors: Chemistry and Bioactivities. Cai YS; Xie HX; Zhang JH; Li Y; Zhang J; Wang KM; Jiang CS Curr Top Med Chem; 2023; 23(26):2488-2526. PubMed ID: 37818579 [TBL] [Abstract][Full Text] [Related]
19. Exploring the Dual Inhibitory Activity of Novel Anthranilic Acid Derivatives towards α-Glucosidase and Glycogen Phosphorylase Antidiabetic Targets: Design, In Vitro Enzyme Assay, and Docking Studies. Ihmaid S Molecules; 2018 May; 23(6):. PubMed ID: 29844263 [TBL] [Abstract][Full Text] [Related]